IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지

Depletion of Cytoplasmic Tail of UL18 Enhances and Stabilizes the Surface Expression of UL18

  • Kim, Jung-Sik (Department of Microbiology and Immunology, Seoul National University College of Medicine) ;
  • Kim, Bon-Gi (Department of Microbiology and Immunology, Seoul National University College of Medicine) ;
  • Yoon, Il-Hee (Department of Microbiology and Immunology, Seoul National University College of Medicine) ;
  • Kim, Sang-Joon (Xenotransplantation Research Center) ;
  • Park, Chung-Gyu (Department of Microbiology and Immunology, Seoul National University College of Medicine)
  • Published : 2008.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Human cytomegalovirus UL18, a MHC class I homologue, has been considered a natural killer (NK) cell decoy. It ligates LIR-1/ILT2 (CD85j), an NK inhibitory receptor, to prevent lysis of infected target cells. However, precise role of UL18 to NK cell cytotoxicity is yet elusive. Difficulty in clarifying the function of UL18 lies in complication in detecting UL18 mainly due to low level expression of UL18 on the surface and gradual loss of its expression. Methods: To overcome this hurdle, cDNA of cytoplasmic tail-less UL18 was constructed and expressed in swine endothelial cell (SEC). The expression level and its stability in the cell surface were monitored with FACS analysis. Results: Surface expression of UL18 is up-regulated by removing cytoplasmic tail portion from UL18F (a full sequence of UL18). SECs transfected with a cDNA of UL18CY (a cytoplasmic tail-less UL18) stably expressed UL18 molecule on the surface without gradual loss of its expression during 6 week continuous cultures. In the NK cytotoxicity assay, UL18 functions either inhibiting or activating NK cell cytotoxicity according to the source of NK cells. We found that there is individual susceptibility in determining whether the engagement of NK cell and UL18 results in overall inhibiting or activating NK cell cytotoxicity. Conclusion: In this study, we found that cytoplasmic tail is closely related to the regulatory function for controlling surface expression of UL18. Furthermore, by constructing stable cell line in which UL18 expression is up-regulated and stable, we provided a useful tool to clarify exact functions of UL18 on various immune cells having ILT2 receptor.

Keywords

References

  1. Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod'homme V, Aicheler R, McSharry BP, Rickards CR, Cochrane D, Llewellyn-Lacey S, Wang EC, Griffin CA, Davison AJ: Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 41;206-212, 2008 https://doi.org/10.1016/j.jcv.2007.10.027
  2. Fahnestock ML, Johnson JL, Feldman RM, Neveu JM, Lane WS, Bjorkman PJ: The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3;583-590, 1995 https://doi.org/10.1016/1074-7613(95)90129-9
  3. Chapman TL, Heikeman AP, Bjorkman PJ: The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11;603-613, 1999 https://doi.org/10.1016/S1074-7613(00)80135-1
  4. Leong CC, Chapman TL, Bjorkman PJ, Formankova D, Mocarski ES, Phillips JH, Lanier LL: Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 187;1681-1687, 1998 https://doi.org/10.1084/jem.187.10.1681
  5. Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL: The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386;514-517, 1997 https://doi.org/10.1038/386514a0
  6. Kim JS, Choi SE, Yun IH, Kim JY, Ahn C, Kim SJ, Ha J, Hwang ES, Cha CY, Miyagawa S, Park CG: Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis. Biochem Biophys Res Commun 315;144-150, 2004 https://doi.org/10.1016/j.bbrc.2004.01.027
  7. Wagner CS, Riise GC, Bergstrom T, Karre K, Carbone E, Berg L: Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J Immunol 178;3536-3543, 2007 https://doi.org/10.4049/jimmunol.178.6.3536
  8. Prod'homme V, Griffin C, Aicheler RJ, Wang EC, McSharry BP, Rickards CR, Stanton RJ, Borysiewicz LK, Lopez-Botet M, Wilkinson GW, Tomasec P: The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. J Immunol 178;4473-4481, 2007 https://doi.org/10.4049/jimmunol.178.7.4473
  9. Liszewski MK, Tedja I, Atkinson JP: Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains. J Biol Chem 269;10776-10779, 1994
  10. Beck S, Barrell BG: Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331;269-272, 1988 https://doi.org/10.1038/331269a0
  11. Griffin C, Wang EC, McSharry BP, Rickards C, Browne H, Wilkinson GW, Tomasec P: Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18. J Gen Virol 86;2999-3008, 2005 https://doi.org/10.1099/vir.0.81126-0
  12. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML: A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7;273-282, 1997 https://doi.org/10.1016/S1074-7613(00)80529-4
  13. Saverino D, Ghiotto F, Merlo A, Bruno S, Battini L, Occhino M, Maffei M, Tenca C, Pileri S, Baldi L, Fabbi M, Bachi A, De Santanna A, Grossi CE, Ciccone E: Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J Immunol 172;5629-5637, 2004 https://doi.org/10.4049/jimmunol.172.9.5629
  14. Vitale M, Castriconi R, Parolini S, Pende D, Hsu ML, Moretta L, Cosman D, Moretta A: The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. Int Immunol 11;29-35, 1999 https://doi.org/10.1093/intimm/11.1.29
  15. Hengel H, Koopmann JO, Flohr T, Muranyi W, Goulmy E, Hammerling GJ, Koszinowski UH, Momburg F: A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6;623-632, 1997 https://doi.org/10.1016/S1074-7613(00)80350-7
  16. Fanger NA, Cosman D, Peterson L, Braddy SC, Maliszewski CR, Borges L: The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur J Immunol 28;3423-3434, 1998 https://doi.org/10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2
  17. Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL: HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 101;191-200, 2000 https://doi.org/10.1046/j.1365-2567.2000.00109.x
  18. Forte P, Pazmany L, Matter-Reissmann UB, Stussi G, Schneider MK, Seebach JD: HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells. J Immunol 167;6002-6008, 2001 https://doi.org/10.4049/jimmunol.167.10.6002
  19. Horuzsko A, Lenfant F, Munn DH, Mellor AL: Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 13;385-394, 2001 https://doi.org/10.1093/intimm/13.3.385
  20. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED: Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 98;12150-12155, 2001